Reomune 3

Company: Ceva Biomune

Avian Reovirus Vaccine, Standard and SS412 Types, Killed Virus

U.S. Vet. Lic. No.: 368

Contents: REOMUNE^® 3 is an inactivated oil emulsion vaccine containing three avian reoviruses including strain S1133 (a tenosynovitis pathotype), strain 2408 (a malabsorption pathotype) and strain SS412 (a distinct serotype from the S1133 standard type reoviruses and a causative agent of proventriculitis and malabsorption in broilers). All reoviruses contained in REOMUNE^® 3 are of chicken embryo origin.

The vaccine has undergone rigid potency, safety and purity tests and meets Biomune and USDA requirements.

Reomune 3 Indications

The vaccine is indicated for use in healthy replacement chickens and breeder hens against diseases caused by avian reoviruses. Breeder vaccination provides maternal antibody to the progeny for the prevention of early exposure to tenosynovitis (viral arthritis) and malabsorption which includes feed passage and proventriculitis.

Dosage and Administration

A prime with live infectious tenosynovitis vaccine is recommended at least four (4) weeks in advance of administration of the killed vaccine.

Vaccinate chickens with 0.5 mL per bird. The vaccine is to be administered by the subcutaneous route in the back of the neck, midway between the head and the body, in a direction away from the head. Do not inject into muscle or vertebrae.

Refer to the product label for specific use directions and precautions.

Precaution(s): Store the vaccine at 35°-45°F (2°-7°C). Do not freeze.

Warning(s): Do not vaccinate with oil emulsion vaccine within 42 days before slaughter.

Avoid injection of the vaccine into a human. Should accidental injection of a human occur, seek medical attention immediately since a serious localized reaction may result.

Presentation: 1,000 dose (500 mL) bottle.

CPN: 11290273